Supporting the first line of defense in a pandemic
Lateral flow assays are empowering the fight against COVID-19 and in this article, experts in the field tell us more about this technology, highlighting recent advances and challenges
Lateral flow assays are empowering the fight against COVID-19 and in this article, experts in the field tell us more about this technology, highlighting recent advances and challenges
This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency
Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR
Explore topics from immuno-oncology, Raman spectroscopy, in vitro diagnostics, and clinical research
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant
The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools
A response to the unprecedented global demand for key scientific resources
By consolidating up to four analytical units on a single platform, testing efficiency in high-volume labs is increased
Therapy used for the treatment of certain patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinoma
Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
This partnership aims to offer an accelerated route to market rapid test technologies
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
The company is set to support the $12 billion expansion in COVID-19 testing as vaccinations increase
Explore topics from immunoassays, immunotherapeutics and immuno-oncology to Raman spectroscopy, metabolomics, and COVID-19
This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative